Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04578938 · ClinicalTrials.gov registry record · Phase 4
Ketamine + Cognitive Training for Suicidality in the Medical Setting
A Phase 4 study of Suicide, Attempted, sponsored by Rebecca Price.
- Active
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04578938 is a Phase 4 study of Suicide, Attempted that is active but no longer recruiting, run by Rebecca Price. The registered enrollment target is 200 participants, below the 374-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04578938, a Phase 4 study of Suicide, Attempted, is active but no longer recruiting, sponsored by Rebecca Price.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat suicidality more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.
Conditions Studied
Interventions
- BEHAVIORAL Sham Training
- BEHAVIORAL Cognitive training
- DRUG Intravenous ketamine
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2026-12-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04578938
The ClinicalTrials.gov registry entry for NCT04578938 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 374-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (47% lower). The listed sponsor is Rebecca Price, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suicide, Attempted appearing as the primary indexed condition, and to 3 interventions - of which Sham Training is the first listed.
NCT04578938 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04578938 about?
NCT04578938 is a clinical study titled "Ketamine + Cognitive Training for Suicidality in the Medical Setting". This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introd...
What is the current status of trial NCT04578938?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2021-03-15. Estimated completion is 2026-12-02.
What conditions does trial NCT04578938 study?
This clinical trial studies the following conditions: Suicide, Attempted.
What interventions are being tested in trial NCT04578938?
The interventions under investigation include: Sham Training (BEHAVIORAL), Cognitive training (BEHAVIORAL), Intravenous ketamine (DRUG).
Who is sponsoring clinical trial NCT04578938?
This trial is sponsored by Rebecca Price, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04578938 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide, Attempted
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Virtual Reality Lethal Means Safety Training
RECRUITING · NA
-
Skills to Enhance Positivity in Suicidal Youth
RECRUITING · NA
-
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
RECRUITING · NA
-
Ketamine Treatment of Youth Suicide Attempters
RECRUITING · Phase 3
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
-
Enhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals With PTSD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.